This compound is a pharmaceutical intermediate specifically used in the manufacture of ledipasvir, an antiviral agent. It is a stereochemically defined molecule containing multiple aromatic rings, halogen atoms, and a spirocyclic amine structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1256388-49-4
Tert-butyl (6S)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate
pharmaceutical intermediate
Tert-butyl (1R,3S,4S)-3-(6-bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
pharmaceutical intermediate
N-[(1S)-1-[[(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl]carbonyl]-2-methylpropyl]carbamic acid methyl ester
pharmaceutical intermediate
Ledipasvir Intermediate
pharmaceutical intermediate
2-methyl-2-(4-vinylphenyl)propanoic acid
pharmaceutical intermediate
2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid
pharmaceutical intermediate
benzyl (6S)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate
HTUJXNNBCXWTGU-SANMLTNESA-N
C1CC12C[C@H](N(C2)C(=O)OCC3=CC=CC=C3)C4=NC=C(N4)C5=CC6=C(C=C5)C7=C(C6(F)F)C=C(C=C7)Br
—